Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -3767.20% is 3459% below its 5-year average of -105.84%, near the high end of its 5-year range (-780350.00%–71.45%).
98.82% above its 12-month average of -320364.19%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -780350.00%.
GROSS MARGIN
-3767.20%
GROSS MARGIN AVG TTM
-320364.19%
GROSS MARGIN AVG 3Y
-8529.75%
GROSS MARGIN AVG 5Y
-105.84%
GROSS MARGIN AVG 10Y
5.96%
GROSS MARGIN AVG 15Y
30.73%
GROSS MARGIN AVG 20Y
40.49%
CURRENT VS TTM AVG
+98.82%
CURRENT VS 3Y AVG
+55.83%
CURRENT VS 5Y AVG
-3459.21%
CURRENT VS 10Y AVG
-63282.46%
CURRENT VS 15Y AVG
-12358.26%
CURRENT VS 20Y AVG
-9404.58%
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
-9443.25%
vs the sector median at left
Ainos, Inc.
Market Cap
$9.72M
Gross Margin
-3767.20%
TTM Avg
-320364.19%
3Y Avg
-8529.75%
5Y Avg
-105.84%
Market Cap
$9.57M
Gross Margin
67.30%
TTM Avg
49.28%
3Y Avg
20.15%
5Y Avg
20.34%
Market Cap
$10.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.32M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.22M
Gross Margin
92.64%
TTM Avg
97.85%
3Y Avg
48.93%
5Y Avg
32.62%
Market Cap
$9.17M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.31M
Gross Margin
-16431.82%
TTM Avg
-8215.91%
3Y Avg
-4057.95%
5Y Avg
-2671.97%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ainos, Inc. (AIMD) | $9.72M | -3767.20% | -320364.19% | -8529.75% | -105.84% |
| MetaVia Inc. (MTVA)vs › | $9.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | 67.30% | 49.28% | 20.15% | 20.34% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 35.95% | 35.13% | 34.24% | 39.24% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.22M | 92.64% | 97.85% | 48.93% | 32.62% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.31M | -16431.82% | -8215.91% | -4057.95% | -2671.97% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.34M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-3767.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -780350.00% |
| 2026-03-31 | -729612.42% |
| 2025-12-31 | -10724.33% |
| 2025-09-30 | -55604.57% |
| 2025-06-30 | -25529.62% |
| 2025-03-31 | -1025.63% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -29.07% |
| 2023-12-31 | -559.70% |
| 2023-09-30 | -258.83% |
| 2023-06-30 | -95.47% |
| 2023-03-31 | -105.13% |
| 2022-12-31 | 44.30% |
| 2022-09-30 | 33.10% |
| 2022-06-30 | 49.90% |
| 2022-03-31 | 52.89% |
| 2021-12-31 | 62.93% |
| 2021-09-30 | 71.45% |
| 2021-06-30 | 65.76% |
| 2021-03-31 | 41.11% |
| 2020-12-31 | 91.85% |
| 2020-09-30 | 35.94% |
| 2020-06-30 | 39.67% |
| 2020-03-31 | 28.91% |
| 2019-12-31 | 6.19% |
| 2019-09-30 | 29.63% |
| 2019-06-30 | 7.10% |
| 2019-03-31 | 33.32% |
| 2018-12-31 | 32.40% |
| 2018-09-30 | -12.63% |
| 2018-06-30 | -182.80% |
| 2018-03-31 | 23.42% |
| 2017-12-31 | -255.63% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 76.53% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 215.91% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | -15.91% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 60.00% |
| 2013-06-30 | 60.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 60.00% |
| 2012-06-30 | 60.00% |
| 2012-03-31 | 60.00% |
| 2011-12-31 | 60.28% |
| 2011-09-30 | 99.62% |
| 2011-06-30 | 46.47% |
| 2011-03-31 | 47.39% |
| 2010-12-31 | 37.93% |
| 2010-09-30 | 40.04% |
| 2010-06-30 | 32.61% |
| 2010-03-31 | 40.63% |
| 2009-12-31 | 58.40% |
| 2009-09-30 | 49.98% |
| 2009-06-30 | 67.89% |
| 2009-03-31 | 54.49% |
| 2008-12-31 | -11.91% |
| 2008-09-30 | 99.66% |
| 2008-06-30 | 99.55% |
| 2008-03-31 | 66.10% |
| 2007-12-31 | 250.75% |
| 2007-09-30 | 98.84% |
| 2007-06-30 | 69.71% |
| 2007-03-31 | 99.59% |
| 2006-12-31 | 99.37% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 87.29% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | -23.89% |
| 2005-09-30 | 82.15% |
| 2005-06-30 | 91.84% |
| 2005-03-31 | 99.09% |
| 2004-12-31 | 99.54% |
| 2004-09-30 | 96.67% |
| 2004-06-30 | 52.39% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.19% |
| 2003-09-30 | 99.93% |
| 2003-06-30 | 87.05% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 102.80% |
| 2002-09-30 | 88.37% |